Familial HDL (high-density lipoprotein) deficiency is a rare hereditary disease characterized by severe hypolipidemia with deficiency or absence of HDL, as well as high levels of triglycerides and cholesterol in the blood. High-density lipoproteins play a key role in the transport of cholesterol, facilitating its elimination from the body. In this regard, their deficiency leads to a number of cardiovascular diseases, as well as the possibility of the formation of atherosclerotic plaques. The disease is most often caused by genetic mutations that lead to disruption of lipoprotein metabolism and represent an important problem both in clinical practice and in research.
History of the disease and interesting historical facts
Familial HDL deficiency was first described at the end of the 20th century. Among the historical facts, it is worth noting that the study of the genetic aspects of this disease began with the study of family cases in various populations. In 1991, scientists Dallas and Paul identified key genes responsible for HDL metabolism. These discoveries became the basis for future breakthroughs in understanding the hereditary nature of the disease and the development of diagnostic methods. It is also worth noting that clinical observations of patients played a significant role in the study of the disease, which allowed a better understanding of the pathogenesis and mechanisms leading to cardiovascular complications.
Epidemiology
The epidemiology of familial HDL deficiency indicates that it is rare. According to various sources, the prevalence of this disease is approximately 1 case per 1 million population. However, it is believed that the real figure may be higher, since many cases may remain unrecognized. The disease is most common in certain ethnic groups, which may be associated with a certain hereditary predisposition. It is important to note that in countries with highly developed health care systems, timely diagnosis and detection of patients most often occur.
Genetic predisposition to this disease
Genetic predisposition to familial HDL deficiency is associated with mutations in the genes responsible for the synthesis of apoA-1, the main component of HDL. The following genes and mutated alleles are most frequently described:
- APOA1 is the gene encoding apolipoprotein A1
- ABCA1 is a gene associated with cholesterol transport.
- LIPC – gene encoding lecithin-cholesterol acyltransferase
According to research, more than 30 different mutations in these genes can lead to severe HDL deficiency and increase the risk of developing cardiovascular diseases.
Risk factors for the development of this disease
Risk factors that contribute to the development of familial HDL deficiency may include the following:
- Heredity – presence of cases of the disease in the family
- Age - increased risk in older adults
- Autoimmune diseases – such as systemic lupus erythematosus
- Chronic infections and inflammatory processes
- Lifestyle - lack of physical activity and unhealthy diet
These factors can not only contribute to the development of the disease, but also worsen its course.
Diagnosis of this disease
Diagnosis of familial HDL deficiency is based on a combination of clinical, laboratory and instrumental methods. The main symptoms include:
- Hyperlipidemia – high levels of triglycerides and cholesterol
- Cardiovascular diseases - chest pain, myocardial infarction
- Hepatosplenomegaly – enlargement of the liver and spleen
Laboratory tests include:
- Lipid profile – determination of cholesterol and triglyceride levels
- Genetic testing – detection of mutations in genes responsible for HDL metabolism
Radiological examinations may include:
- Ultrasound examination of abdominal organs to assess liver condition
- Angiography to determine the condition of the vessels
The differential diagnosis should exclude other forms of hyperlipidemia and liver disease.
Treatment
Treatment of familial HDL deficiency may involve both general measures and specific therapeutic approaches. General recommendations include:
- Diet therapy - reducing the consumption of saturated fats and carbohydrates
- Physical activity – regular exercise to improve metabolism
Pharmacological treatment may include:
- Statins – to lower cholesterol levels
- Fibrates - to reduce triglycerides
- Nicotinic acid - to increase HDL levels
Surgical treatment in the form of liver transplantation may be indicated in critical cases when the course of the disease is unfavorable.
List of medications used to treat this disease
- Atorvastatin
- Rosuvastatin
- Fenofibrate
- A nicotinic acid
- Omega-3 fatty acids
Disease monitoring
Monitoring of familial HDL deficiency includes regular lipid level check-ups, clinical monitoring for the occurrence of cardiovascular complications, and adequate treatment of comorbidities. Disease prognosis depends on the timeliness of diagnosis and the quality of LDL management. Complications may include:
- Myocardial infarction
- Persistent atherosclerosis
- Cerebrovascular events
Age-related features of the disease
Familial HDL deficiency may manifest itself differently in different age groups. In children and adolescents, the disease may be asymptomatic or manifest with mild clinical signs, while in middle-aged and elderly patients, the risk of cardiovascular complications increases significantly.
Questions and Answers
- What is familial HDL deficiency? It is a rare inherited disorder characterized by low HDL levels and high levels of triglycerides and cholesterol in the blood, which leads to a risk of cardiovascular disease.
- What is the genetic basis for familial HDL deficiency? The main genes associated with the disease are APOA1, ABCA1 and LIPC, which are responsible for HDL metabolism.
- What diagnostic methods are used? Diagnostics include laboratory tests of the lipid profile, genetic testing and instrumental methods such as ultrasound of the abdominal organs.
- How is this disease treated? Treatment includes diet therapy, physical activity, and pharmacological treatment with statins and fibrates.
- What complications can arise with this disease? Potential complications include myocardial infarction, atherosclerosis, and cerebrovascular events.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov suggests the following for patients with familial HDL deficiency:
- Have regular medical checkups to monitor your lipid levels.
- Watch your lifestyle: proper nutrition and physical activity are vital.
- Do not ignore your family history and do not hesitate to discuss it with your doctor, as early diagnosis plays a key role in successful treatment.
These measures can significantly improve quality of life and reduce the risk of serious complications.
